MAPharm OÜRegistered
Key figures
Ratios
2025Balance sheet structure
Quarterly figures
| Quarter | Revenue | Number of employees | Labour taxes |
|---|---|---|---|
| Q3 2026 | 1 533 795 € | 23 | 88 706 € |
| Q2 2026 | 1 198 341 € | 25 | 74 325 € |
| Q1 2026 | 1 295 633 € | 22 | 70 207 € |
| Q4 2025 | 1 190 552 € | 22 | 72 780 € |
| Q3 2025 | 1 065 564 € | 21 | 77 224 € |
| Q2 2025 | 1 027 627 € | 21 | 73 185 € |
| Q1 2025 | 1 414 459 € | 21 | 69 862 € |
Source: Tax Board open data — based on VAT returns, may not exactly match revenue in the annual report. Updated quarterly.
Summary of financial statements2019–2025
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Balance sheet — assets | |||||||
| Total current assets | 295 385 | 319 287 | 358 172 | 488 257 | 777 721 | 1 114 510 | 757 172 |
| Total non-current assets | 94 801 | 73 417 | 54 544 | 17 636 | 20 145 | 14 135 | 7701 |
| Total assets | 390 186 | 392 704 | 412 716 | 505 893 | 797 866 | 1 128 645 | 764 873 |
| Balance sheet — liabilities and equity | |||||||
| Current liabilities | 518 125 | 574 854 | 539 096 | 527 057 | 945 750 | 1 235 482 | 1 137 442 |
| Non-current liabilities | 46 500 | 46 500 | 46 500 | 46 500 | 46 500 | 46 500 | 46 500 |
| Total liabilities | 564 625 | 621 354 | 585 596 | 573 557 | 992 250 | 1 281 982 | 1 183 942 |
| Share capital | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 | 2500 |
| Retained earnings of previous periods | −87 566 | −176 939 | −231 150 | −175 380 | −70 164 | −196 884 | −155 837 |
| Profit for the year | −89 373 | −54 211 | 55 770 | 105 216 | −126 720 | 41 047 | −265 732 |
| Total equity | −174 439 | −228 650 | −172 880 | −67 664 | −194 384 | −153 337 | −419 069 |
| Income statement | |||||||
| Sales revenue | 1 103 019 | 1 913 331 | 2 249 721 | 2 536 605 | 3 166 227 | 4 017 894 | 4 174 860 |
| Operating profit | −87 143 | −50 511 | 59 154 | 108 443 | −123 938 | 43 838 | −262 948 |
| Profit before income tax | −89 373 | −54 211 | 55 770 | 105 216 | −126 720 | 41 047 | −265 732 |
| Profit for the reporting year | −89 373 | −54 211 | 55 770 | 105 216 | −126 720 | 41 047 | −265 732 |
| Labour costs | 223 412 | 342 223 | 367 197 | 398 199 | 507 806 | 679 901 | 729 636 |
| Depreciation of non-current assets | — | — | — | — | — | — | — |
| Other indicators | |||||||
| Employees | 9 | 11 | 14 | 12 | 19 | 16 | 17 |
| Calculated dividend | — | 0 | 0 | 0 | 0 | 0 | 0 |
A dash (—) means the report has not been filed or the line is not reported; 0 is a zero stated in the report.
Risks and obligations1 note5 clear
Data from public registers, not a credit rating.
Connections graph
Click a node to see its other connections.
Annual reportsPDF, XBRL
Loading list of reports…
Source: e-Business Register (RIK). Files open/download directly from the official register.
Summary: MAPharm OÜ
Overview
MAPharm OÜ (registry code 14292621) is a private limited company (OÜ). The company was entered in the Commercial Register in 2017 and has been registered for 9 years. Registered location: Nõmme linnaosa, Tallinn, Harju maakond. According to the latest annual report, the main activity is ravimite jaemüük (EMTAK 47731). The company is registered for VAT (VAT number EE102038190).
Financial results
Revenue in financial year 2025 was 4 174 860 €, up 3,9% on the previous year (4 017 894 €). From 2019 to 2025, revenue grew by an average of 24,8% per year. This is the company's highest revenue among the published years (2019–2025). Financial year 2025 ended with a loss of 265 732 €. The company was profitable in 3 of the 7 published financial years. In financial year 2025 the company had 17 employees (16 a year earlier). Revenue per employee was 245 580 €.
Latest quarterly figures
According to the Tax and Customs Board, turnover in Q3 2026 was 1 533 795 €, up 43,9% on the same quarter a year earlier. The company had 23 employees in that quarter. Labour taxes paid in the quarter: 88 706 €. Based on labour taxes, the estimated average gross salary in Q3 2026 was about 2400 € per month.
Management and owners
The company has one management board member. The sole owner of the company is a private individual.
Points to note
Equity was negative at the end of financial year 2025 (−419 069 €). Equity is below half of the share capital (2500 €); in this case the Commercial Code requires measures to restore equity.
Data sources and freshness
Register data (name, address, legal form, management board and owners) come from the Commercial Register of the Centre of Registers and Information Systems (RIK); changes are read from RIK every night. Financial figures come from annual reports; the latest report (financial year 2025) was filed on 30.06.2026. Quarterly turnover, employee numbers and labour taxes come from the open data of the Tax and Customs Board (EMTA); latest quarter Q3 2026. Changes, averages and ratios are calculated by entity.ee from open data and are not an official assessment.